ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma

Cai, Yonghua; Liang, Xianqiu; Zhan, Zhengming; Zeng, Yu; Lin, Jie; Xu, Anqi; Xue, Shuaishuai; Xu, Wei; Chai, Peng; Mao, Yangqi; Song, Zibin; Han, Lei; Xiao, Jianqi*; Song, Ye*; Zhang, Xian*南方医科大学; y
Frontiers in Cell and Developmental Biology2022-1-31DOI: 10.3389/fcell.2021.812422
6被引7阅读
引用收藏
分享

摘要

Background: Gliomas are highly lethal brain tumors. Despite multimodality therapy with surgery, radiotherapy, chemotherapy, and immunotherapy, glioma prognosis remains poor. Ferroptosis is a crucial tumor suppressor mechanism that has been proven to be effective in anticancer therapy. However, the implications of ferroptosis on the clinical prognosis, chemotherapy, and immune checkpoint inhibitor (ICI) therapy for patients with glioma still need elucidation.Methods: Consensus clustering revealed two distinct ferroptosis-related subtypes based on the Cancer Genome Atlas (TCGA) glioma dataset (n = 663). Subsequently, the ferroptosis-related gene prognostic index (FRGPI) was constructed by weighted gene co-expression network analysis (WGCNA) and "stepAIC" algorithms and validated with the Chinese Glioma Genome Atlas (CGGA) dataset (n = 404). Subsequently, the correlation among clinical, molecular, and immune features and FRGPI was analyzed. Next, the temozolomide sensitivity and ICI response for glioma were predicted using the "pRRophetic" and "TIDE" algorithms, respectively. Finally, candidate small molecular drugs were defined using the connectivity map database based on FRGPI.Results: The FRGPI was established based on the HMOX1, TFRC, JUN, and SOCS1 genes. The distribution of FRGPI varied significantly among the different ferroptosis-related subtypes. Patients with high FRGPI had a worse overall prognosis than patients with low FRGPI, consistent with the results in the CGGA dataset. The final results showed that high FRGPI was characterized by more aggressive phenotypes, high PD-L1 expression, high tumor mutational burden score, and enhanced temozolomide sensitivity; low FRGPI was associated with less aggressive phenotypes, high microsatellite instability score, and stronger response to immune checkpoint blockade. In addition, the infiltration of memory resting CD4(+) T cells, regulatory T cells, M1 macrophages, M2 macrophages, and neutrophils was positively correlated with FRGPI. In contrast, plasma B cells and naive CD4(+) T cells were negatively correlated. A total of 15 potential small molecule compounds (such as depactin, physostigmine, and phenacetin) were identified.Conclusion: FRGPI is a promising gene panel for predicting the prognosis, immune characteristics, temozolomide sensitivity, and ICI response in patients with glioma.

学科与关键词

关键词
ferroptosisgliomatemozolomideimmune checkpoint inhibitortumor microenvironmentferroptosis-based anticancer therapyimmunotherapy
相关
加载中…
  • Characterization of the Ferroptosis-Related Genes for Prognosis and Immune Infiltration in Low-Grade Glioma
    Yan, Xiuwei; Ji, Hang; Liu, Zhihui; Ma, Shuai; Dong, Jiawei; Jiang, Xiaoyan; Hu, Xueyan; Wang, Fang; Zhao, Hongtao; Jin, Jiaqi; Zhang, Jiheng; Wang, Nan; Du, Jianyang*; Hu, Shaoshan*Frontiers in Genetics, 2022, 13: 880864.被引 1
  • Ferroptosis-Related Gene Contributes to Immunity, Stemness and Predicts Prognosis in Glioblastoma Multiforme
    Dong, Jiawei; Zhao, Hongtao; Wang, Fang; Jin, Jiaqi; Ji, Hang; Yan, Xiuwei; Wang, Nan; Zhang, Jiheng; Hu, Shaoshan*Frontiers in Neurology, 2022, 13: 829926.被引 6
  • A novel 25-ferroptosis-related gene signature for the prognosis of gliomas
    Peng, Xiaojiang; Liu, Chun; Li, Jing; Bao, Zeqing; Huang, Tao; Zeng, Lingfeng; He, Qixiong; Xue, Daojin*Frontiers in Oncology, 2023, 13: 1128278.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Cell and Developmental Biology
发表日期
2022-01-31
卷期
第 9 卷
页码
812422
DOI
10.3389/fcell.2021.812422
期刊等级
3区
成果收录
SCIE

作者

  • C

    Cai, Yonghua (第一作者)

    southern med univ

  • L

    Liang, Xianqiu

    southern med univ

查看全部 15 位作者收起作者
  • Z

    Zhan, Zhengming

    southern med univ

  • Z

    Zeng, Yu

    southern med univ

  • L

    Lin, Jie

    southern med univ

  • X

    Xu, Anqi

    southern med univ

  • X

    Xue, Shuaishuai

    southern med univ

  • X

    Xu, Wei

    southern med univ

  • C

    Chai, Peng

    southern med univ

  • M

    Mao, Yangqi

    southern med univ

  • S

    Song, Zibin

    southern med univ

  • H

    Han, Lei

    southern med univ

  • X

    Xiao, Jianqi (通讯)

  • S

    Song, Ye (通讯)

    southern med univ

  • Z

    Zhang, Xian (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417